Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro

BMC Research Notes

Kevin S Akers²  Clinton K Murray¹  Joseph C Wenke²  Sharanda K Hardy²  Desiree R Romano²  Meghan E Samberg²  Carlos J Sanchez²  Anthony P Cardile¹ 

[1] Department of Medicine, Infectious Disease Service, Brooke Army Medical Center, 3551 Roger Brooke Drive, JBSA Fort Sam Houston, TX 78234, USA;Extremity Trauma and Regenerative Medicine Task Area, United States Army Institute of Surgical Research, JBSA Fort Sam Houston, TX, USA

关键词: Vancomycin;    Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs);    Staphylococcus aureus;    Biofilm;    Human plasma;   

Others  :  1131866
DOI  :  10.1186/1756-0500-7-457

 received in 2014-02-11, accepted in 2014-06-30,  发布年份 2014

【 摘 要 】

Background

Microbial biofilms have been associated with the development of chronic human infections and represent a clinical challenge given their increased antimicrobial tolerance. Staphylococcus aureus is a major human pathogen causing a diverse range of diseases, of which biofilms are often involved. Staphylococcal attachment and the formation of biofilms have been shown to be facilitated by host factors that accumulate on surfaces. To better understand how host factors enhance staphylococcal biofilm formation, we evaluated the effect of whole human plasma on biofilm formation in clinical isolates of S. aureus and the expression of seven microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) known to be involved in biofilm formation by quantitative real-time PCR. We also evaluated whether plasma augmented changes in S. aureus biofilm morphology and antimicrobial resistance.

Results

Exposure of clinical isolates of S. aureus to human plasma (10%) within media, and to a lesser extent when coated onto plates, significantly enhanced biofilm formation in all of the clinical isolates tested. Compared to biofilms grown under non-supplemented conditions, plasma-augmented biofilms displayed significant changes in both the biofilm phenotype and cell morphology as determined by confocal scanning laser microscopy (CLSM) and scanning electron microscopy (SEM), respectively. Exposure of bacteria to plasma resulted in a significant fold-increase in MSCRAMM expression in both a time and isolate-dependent manner. Additionally, plasma-augmented biofilms displayed an increased tolerance to vancomycin compared to biofilms grown in non-supplemented media.

Conclusions

Collectively, these studies support previous findings demonstrating a role for host factors in biofilm formation and provide further insight into how plasma, a preferred growth medium for staphylococcal biofilm formation enhances as well as augments other intrinsic properties of S. aureus biofilms. Consequently, these findings indicate that incorporation of host factors may be necessary to better replicate in vivo conditions and for the best utility of a clinical biofilm assay to evaluate the process of biofilm formation and treatments.

【 授权许可】

   
2014 Cardile et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Costerton JW: Introduction to biofilm. Int J Antimicrob Agents 1999, 11:217-221. discussion 237–219
• [2]Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
• [3]Hall-Stoodley L, Costerton JW, Stoodley P: Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004, 2:95-108.
• [4]James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS: Biofilms in chronic wounds. Wound Repair Regen 2008, 16:37-44.
• [5]Aly R, Levit S: Adherence of Staphylococcus aureus to squamous epithelium: role of fibronectin and teichoic acid. Rev Infect Dis 1987, 9(Suppl 4):S341-S350.
• [6]Vaudaux P, Pittet D, Haeberli A, Huggler E, Nydegger UE, Lew DP, Waldvogel FA: Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989, 160:865-875.
• [7]Wagner C, Aytac S, Hansch GM: Biofilm growth on implants: bacteria prefer plasma coats. Int J Artif Organs 2011, 34:811-817.
• [8]Bjarnsholt T, Alhede M, Alhede M, Eickhardt-Sorensen SR, Moser C, Kuhl M, Jensen PO, Hoiby N: The in vivo biofilm. Trends Microbiol 2013, 21:466-474.
• [9]Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, Peters G, Waldvogel FA: Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988, 158:693-701.
• [10]Bridges M Jr, Morris D, Hall JR, Deitch EA: Effects of wound exudates on in vitro immune parameters. J Surg Res 1987, 43:133-138.
• [11]Espersen F, Wilkinson BJ, Gahrn-Hansen B, Thamdrup Rosdahl V, Clemmensen I: Attachment of staphylococci to silicone catheters in vitro. APMIS 1990, 98:471-478.
• [12]Chang P, Aronson DL, Borenstein DG, Kessler CM: Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation. Am J Hematol 1995, 50:79-83.
• [13]Henderson JM, Stein SF, Kutner M, Wiles MB, Ansley JD, Rudman D: Analysis of twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen. Ann Surg 1980, 192:738-742.
• [14]Hourigan LA, Linfoot JA, Chung KK, Dubick MA, Rivera RL, Jones JA, Salinas RD, Mann EA, Wade CE, Wolf SE, Baskin TW: Loss of protein, immunoglobulins, and electrolytes in exudates from negative pressure wound therapy. Nutr Clin Pract 2010, 25:510-516.
• [15]Igarashi Y, Skoner DP, Doyle WJ, White MV, Fireman P, Kaliner MA: Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993, 92:722-731.
• [16]Lehnhardt M, Jafari HJ, Druecke D, Steinstraesser L, Steinau HU, Klatte W, Schwake R, Homann HH: A qualitative and quantitative analysis of protein loss in human burn wounds. Burns 2005, 31:159-167.
• [17]Miller GJ, Howarth DJ, Attfield JC, Cooke CJ, Nanjee MN, Olszewski WL, Morrissey JH, Miller NE: Haemostatic factors in human peripheral afferent lymph. Thromb Haemost 2000, 83:427-432.
• [18]Chen P, Abercrombie JJ, Jeffrey NR, Leung KP: An improved medium for growing Staphylococcus aureus biofilm. J Microbiol Methods 2012, 90:115-118.
• [19]Walker JN, Horswill AR: A coverslip-based technique for evaluating Staphylococcus aureus biofilm formation on human plasma. Front Cell Infect Microbiol 2012, 2:39.
• [20]Elgalai I, Foster HA: Comparison of adhesion of wound isolates of Staphylococcus aureus to immobilized proteins. J Appl Microbiol 2003, 94:413-420.
• [21]Proctor RA, Mosher DF, Olbrantz PJ: Fibronectin binding to Staphylococcus aureus. J Biol Chem 1982, 257:14788-14794.
• [22]Que YA, Haefliger JA, Piroth L, Francois P, Widmer E, Entenza JM, Sinha B, Herrmann M, Francioli P, Vaudaux P, Moreillon P: Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005, 201:1627-1635.
• [23]Atshan SS, Shamsudin MN, Karunanidhi A, van Belkum A, Lung LT, Sekawi Z, Nathan JJ, Ling KH, Seng JS, Ali AM, Abduljaleel SA, Hamat RA: Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA). Infect Genet Evol 2013, 18:106-112.
• [24]Coraca-Huber DC, Fille M, Hausdorfer J, Pfaller K, Nogler M: Evaluation of MBEC-HTP biofilm model for studies of implant associated infections. J Orthop Res 2012, 30:1176-1180.
• [25]Singh R, Ray P, Das A, Sharma M: Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol 2009, 58:1067-1073.
• [26]Qu Y, Daley AJ, Istivan TS, Rouch DA, Deighton MA: Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. J Antimicrob Chemother 2010, 65:1405-1411.
• [27]Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K, Ferraz V, Hiramatsu K: Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003, 41:5-14.
• [28]Blanchette KA, Orihuela CJ: Future perspective on host-pathogen interactions during bacterial biofilm formation within the nasopharynx. Future Microbiol 2012, 7:227-239.
• [29]Bjarnsholt T: The role of bacterial biofilms in chronic infections. APMIS Suppl 2013, 136:1-51.
• [30]Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, Murray CK: Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis 2013, 13:47. BioMed Central Full Text
• [31]Smeltzer MS, Thomas JR, Hickmon SG, Skinner RA, Nelson CL, Griffith D, Parr TR Jr, Evans RP: Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res 1997, 15:414-421.
• [32]Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, Shabb DW, Diep BA, Chambers HF, Otto M, DeLeo FR: Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 2011, 6:e18617.
• [33]Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM: A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003, 29:631-635.
• [34]Coraca-Huber DC, Fille M, Hausdorfer J, Pfaller K, Nogler M: Staphylococcus aureus biofilm formation and antibiotic susceptibility tests on polystyrene and metal surfaces. J Appl Microbiol 2012, 112:1235-1243.